KVP Capital Advisors »

Insmed shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Insmed (INSM) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.0M 29k 174.04

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Axsome Therapeutics (AXSM)
Jazz Pharmaceuticals Call Call Option
Aadi Bioscience (WHWK)
Trevi Therapeutics (TRVI)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)
Travere Therapeutics (TVTX)
Edgewise Therapeutics (EWTX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)

View all positions for KVP Capital Advisors

Top funds holding Insmed

Jpmorgan Chase & Co
Vanguard Group
Darwin Global Management
BlackRock
FMR
Capital Research and Management Company - Division 3
Baker Bros. Advisors
D. E. Shaw & Co
State Street Corporation
Artisan Partners Limited Partnership
Geode Capital Management
Orbis Allan Gray
Rtw Investments
Franklin Resources
Ameriprise Financial

View all funds holding Insmed